Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$112.98 - $319.93 $2.82 Million - $8 Million
-25,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.74 - $139.5 $1.97 Million - $3.49 Million
25,000 New
25,000 $2.79 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Mkp Capital Management, L.L.C. Portfolio

Follow Mkp Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mkp Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Mkp Capital Management, L.L.C. with notifications on news.